Results 11 to 20 of about 25,404 (153)
Chronic cardiorenal syndrome: cardio-renal protective effect of SGLT2i [PDF]
Renal FailureObjectives Chronic cardiorenal syndrome (types 2 and 4) arises from chronic dysfunction of either the heart or kidneys, leading to progressive deterioration of the other organ.
Yixin Zhu +7 more
doaj +2 more sources
Sibjotang Protects against Cardiac Hypertrophy In Vitro and In Vivo
Life, 2023 Cardiac hypertrophy is developed by various diseases such as myocardial infarction, valve diseases, hypertension, and aortic stenosis. Sibjotang (十棗湯, Shizaotang, SJT), a classic formula in Korean traditional medicine, has been shown to modulate the ...
Chan-Ok Son +7 more
doaj +1 more source
Plants, 2021 Carthamus tinctorius L., known as safflower, has been used in traditional treatment for cardiovascular, cerebrovascular, and diabetic vascular complications. We proposed to investigate how the ethanol extract of Carthamus tinctorius L.
Yun Jung Lee +10 more
doaj +1 more source
Cardionephrology and cardiorenal disease in Italy: state of the art [PDF]
Reviews in Cardiovascular Medicine, 2021 The interactions and feedback mechanisms involved in heart and renal failure are more complex than previously thought and are grouped under the term “cardio-renal axis”.
Luca Di Lullo +3 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Chronic pancreatitis (CP) is a chronic inflammatory disease of the pancreas with irreversible morphological changes. Arecae pericarpium (ARP), known to improve gastrointestinal disorders, has not yet been reported to inhibit fibrosis in CP. Therefore, we
Bitna Kweon +12 more
doaj +1 more source
Molecules, 2020 Cardiac hypertrophy is a major risk factor for heart failure and leads to cardiovascular morbidity and mortality. Doxorubicin (DOX) is regarded as one of the most potent anthracycline antibiotic agents; however, its clinical usage has some limitations ...
Jung Joo Yoon +6 more
doaj +1 more source
Archives of General Internal Medicine, 2018 Although newer pharmacologic and interventional therapies for the treatment of Heart failure continue to evolve, the optimum strategy of management for the patients with cardio renal syndrome is still unanswered. Various pathophysiologic mechanisms have been proposed including the low output hypothesis and the raised renal venous pressure hypothesis ...
Dhiraj Kumar +5 more
openaire +1 more source
Diagnosing Arterial Stiffness in Pregnancy and Its Implications in the Cardio-Renal-Metabolic Chain
Diagnostics, 2022 Cardio-renal and metabolic modifications during gestation are crucial determinants of foetal and maternal health in the short and long term. The cardio-renal metabolic syndrome is a vicious circle that starts in the presence of risk factors such as ...
Vladiana-Romina Turi +7 more
doaj +1 more source
Novel Biomarkers for Cardio-renal Syndrome [PDF]
Electrolytes & Blood Pressure, 2012 Cardio-renal syndrome (CRS) is a frequent and life-threatening syndrome. It is a disorder of the heart and kidneys in which acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in the other organ. Acute kidney injury (AKI) is strongly associated with increased morbidity and mortality in patients with CRS. Early detection of
Lee, Sul Ra, Jeong, Kyung Hwan
openaire +2 more sources
Cardio-renal-anemia syndrome: A report of three cases
Saudi Journal of Kidney Diseases and Transplantation, 2012 Patients with chronic kidney diseases (CKDs) and cardiovascular diseases (CVDs) present with various degree of anemia. Anemia has been associated with poor outcome in patients with CKD and CVD.
U H Okafor, E I Unuigbe
doaj +1 more source